Jane R. Connor

3.7k citations

50 papers · 3.1k indexed · h-index 29

Impact in

Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
Rheumatology top 2%
- Osteoarthritis Treatment and Mechanisms

Papers in

Biochemistry 9
- Eicosanoids and Hypertension Pharmacology 9
Physiology 23
- Nitric Oxide and Endothelin Effects 19

Co-authors: Pamela T. Manning Mark G. Currie Ronald M. Burch Julio Fernandes Johanne Martel‐Pelletier Dragan Jovanović Jean‐Pierre Pelletier Gina Jerome
Journals: Journal of Medicinal Chemistry (6 papers)Osteoarthritis and Cartilage (4 papers)Inflammation Research (3 papers)The Journal of Immunology (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Jane R. Connor

49 papers receiving 3.0k citations

Peers

Countries citing papers authored by Jane R. Connor

Since Specialization

Citations

This map shows the geographic impact of Jane R. Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane R. Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane R. Connor more than expected).

Fields of papers citing papers by Jane R. Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane R. Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane R. Connor. The network helps show where Jane R. Connor may publish in the future.

Co-authors

The 25 scholars most cited alongside Jane R. Connor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jane R. Connor Line = papers co-authored together Jane R. Connor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Consequences of telomere dysfunction in fibroblasts, club and basal cells for lung fibrosis development Nature Communications ·Sergio Piñeiro‐Hermida, Paula Martínez, Giuseppe Bosso, Juana M. Flores, Sarita Saraswati, Jane R. Connor, Raphaël Lemaire, Marı́a A. Blasco	2022	18
2	Targeting p16-induced senescence prevents cigarette smoke-induced emphysema by promoting IGF1/Akt1 signaling in mice Communications Biology ·Christopher T. Cottage, Norman Peterson, Jennifer Kearley, Aaron A. Berlin, Ximing Xiong, Anna Huntley, Weiguang Zhao, Charles O. Brown, Annik Migneault, Kamelia Zerrouki, G.J. Criner, Roland Kolbeck, Jane R. Connor, Raphaël Lemaire	2019	46
3	Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of plasminogen activator inhibitor-1 Scientific Reports ·Katherine A. Vousden, T. Lundqvist, Bojana Popovic, Brian Naiman, Alan Carruthers, Philip M. Newton, Daniel J. D. Johnson, Anja Pomowski, Trevor Wilkinson, Patrick Dufner, Isabelle de Mendez, Philip R. Mallinder, Clare Murray, Martin Strain, Jane R. Connor, Lynne A. Murray, Matthew A. Sleeman, David C. Lowe, James A. Huntington, Tristan J. Vaughan	2019	24
4	Synergistic Actions of Blocking Angiopoietin-2 and Tumor Necrosis Factor-α in Suppressing Remodeling of Blood Vessels and Lymphatics in Airway Inflammation American Journal Of Pathology ·Catherine T. Le, Grace Laidlaw, Christopher Morehouse, Brian Naiman, Philip Z. Brohawn, Tomas Mustelin, Jane R. Connor, Donald M. McDonald	2015	23
5	Complement C5a potentiates uric acid crystal‐induced IL‐1β production European Journal of Immunology ·Ling–Ling An, Payal Mehta, Linda Xu, Sean Turman, Thornik Reimer, Brian Naiman, Jane R. Connor, Miguel A. F. Sanjuán, Roland Kolbeck, Michael Fung	2014	55
6	Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis Annals of the Rheumatic Diseases ·Sarah Krausz, Samuel García, Carmen A. Ambarus, (unknown), Martyn Foster, Brian Naiman, William P. Iverson, Jane R. Connor, Matthew A. Sleeman, Anthony J. Coyle, Jörg Hamann, Dominique Baeten, Paul P. Tak, Kris A. Reedquist	2012	38
7	Angiopoietin-2-Driven Vascular Remodeling in Airway Inflammation American Journal Of Pathology ·Sébastien P. Tabruyn, Katharine Colton, Tohru Morisada, Jonas Fuxe, Stanley J. Wiegand, Gavin Thurston, Anthony J. Coyle, Jane R. Connor, Donald M. McDonald	2010	51
8	Alterations in both coagulation and fibrinolytic pathways mediate thrombosis in the skin during murine Graft-Versus-Host (GVH)-induced scleroderma (48.5) The Journal of Immunology ·Tim Burwell, Tracy Delaney, Cindy Chen, Jane R. Connor, Anthony J. Coyle, Raphaël Lemaire	2009	1
9	Quantitative ex vivo detection of rodent retinal ganglion cells by immunolabeling Brn-3b Experimental Eye Research ·K. Leahy, Richard Ornberg, Yu Wang, Yanli Zhu, Jeffrey M. Gidday, Jane R. Connor, Martin B. Wax	2004	26
10	Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase Kidney International ·Christopher M. Reilly, Libby W. Farrelly, Dana Viti, Shakisha T. Redmond, Florence N. Hutchison, Phil Ruiz, Pam Manning, Jane R. Connor, Gary S. Gilkeson	2002	48
11	Loss of Retinal Ganglion Cells Following Retinal Ischemia: The Role of Inducible Nitric Oxide Synthase Experimental Eye Research ·Arthur H. Neufeld, Shin-ichiro Kawai, Sucharita Das, Smita Vora, Elizabeth Gachie, Jane R. Connor, Pamela T. Manning	2002	129
12	3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: A potent and highly selective inducible nitric oxide synthase inhibitor Bioorganic & Medicinal Chemistry Letters ·Sofya Tsymbalov, Timothy J. Hagen, William M. Moore, Gina Jerome, Jane R. Connor, Pamela T. Manning, Barnett S. Pitzele, E. Ann Hallinan	2002	17
13	Differential effects of SB 242235, a selective p38 mitogen-activated protein kinase inhibitor, on IL-1 treated bovine and human cartilage/chondrocyte cultures Osteoarthritis and Cartilage ·A M Badger, Amy Roshak, Morgan Cook, Tonie Newman‐Tarr, Barbara A. Swift, Kelly L. Carlson, Jane R. Connor, John C. Lee, Maxine Gowen, Michael W. Lark, Sanjay Kumar	2000	44
14	Temporal relationships of cytokine production in mouse non-lethal sepsis: Effect of nitric oxide synthase inhibitors Inflammation Research ·D. J. Fretland, C. P. Anglin, D. L. Widomski, Jane R. Connor, Pamela S. Wyatt, Pamela T. Manning, Mark G. Currie	1997	5
15	Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. Journal of Clinical Investigation ·Daniela Salvemini, Pamela T. Manning, Ben S. Zweifel, Karen Seibert, Jane R. Connor, Mark G. Currie, Philip Needleman, Jaime L. Masferrer	1995	192
16	2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl] methyl)hexanamide (NPC 15437): a novel inhibitor of protein kinase C interacting at the regulatory domain. Molecular Pharmacology ·James P. Sullivan, Jane R. Connor, B. G. SHEARER, Ronald M. Burch	1992	49
17	NPC 15437 interacts with the C1 domain of protein kinase C An analysis using mutant PKC constructs FEBS Letters ·James P. Sullivan, Jane R. Connor, Carol W. Tiffany, Barry G. Shearer, Ronald M. Burch	1991	22
18	2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)hexanamide (NPC 15437): A selective inhibitor of protein kinase C Inflammation Research ·James P. Sullivan, Jane R. Connor, B. G. SHEARER, Ronald M. Burch	1991	23
19	D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II Peptides ·James Togo, Ronald M. Burch, Christopher J. DeHaas, Jane R. Connor, Larry R. Steranka	1989	23
20	Interleukin 1 stimulates prostaglandin synthesis and cyclic AMP accumulation in Swiss 3T3 fibroblasts: Interactions between two second messenger systems Journal of Cellular Physiology ·Ronald M. Burch, Marsha F. White, Jane R. Connor	1989	36

About Jane R. Connor

Jane R. Connor is a scholar working on Biochemistry, Physiology, Biophysics, Ophthalmology and Hematology, having authored 50 papers that have together received 3.1k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (19 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Inflammatory mediators and NSAID effects (6 papers), Glaucoma and retinal disorders (5 papers), Receptor Mechanisms and Signaling (5 papers), Osteoarthritis Treatment and Mechanisms (5 papers), Electron Spin Resonance Studies (5 papers) and Protein Kinase Regulation and GTPase Signaling (5 papers). The work is most often cited by research in Biochemistry (304 citations), Rheumatology (545 citations), Physiology (915 citations), Pharmacology (573 citations) and Genetics (289 citations). Jane R. Connor has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Pamela T. Manning, Mark G. Currie, Ronald M. Burch, Julio Fernandes, Johanne Martel‐Pelletier, Dragan Jovanović, Jean‐Pierre Pelletier, Gina Jerome, William M. Moore and R. Keith Webber. Their work appears in journals such as Journal of Medicinal Chemistry, Osteoarthritis and Cartilage, Inflammation Research, The Journal of Immunology and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact